Datar Cancer Genetics Limited
Dr. Vineet Datta is a seasoned healthcare executive currently serving as Senior Director of Global Strategy and Executive Director at Datar Cancer Genetics Limited since September 2015. With extensive experience in various leadership roles, Dr. Datta has held positions such as International Advisor at the Royal College of Physicians and Surgeons of Glasgow since March 2014, Group Senior Vice President at Apollo Hospitals from 2014 to 2016, and Medical Director at International SOS from 2008 to 2014. Additional roles include Lead Consultant in Emergency Medicine at Artemis Hospitals and Emergency Medicine Physician at NHS. Dr. Datta's educational background includes an Executive Leadership in Healthcare from Cornell University, Fellow status at the International Medical Science Academy, a certification in Clinical Bioinformatics from The University of Manchester, and various fellowships at the Royal College of Physicians and Surgeons of Glasgow and Royal College of Physicians Edinburgh.
This person is not in the org chart
This person is not in any teams
Datar Cancer Genetics Limited
We are a World-leading molecular oncology facility with a fully equipped laboratory, integrated process platforms, in-house bioinformatics team, and a huge genetic data base for precise and updated reporting. The facility is NABL, ISO, CAP and CLIA accredited. National and international cancer research institutes, and patients from all over the world including US, Switzerland, Germany and UK avail our services. With the help of latest technology and several years of extensive research, we offer highly effective treatment solutions to cancer patients for whom, multiple lines of treatment have failed. Our state-of-the-art cancer research centre is spread over 40,000 sq.ft. with a formidable team of cancer researchers, doctors, scientists and other technologists educated and trained at top universities and institutes around the world. Our entire team is always at the disposal of clinicians and cancer patients to bring cutting-edge treatment options in the most challenging cases.